OTC · BIOE
Bio Essence Corporation
$0.44+$0.02 (+4.76%)
Bio Essence Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.89% below the high.
Loading market information…
OTC · UBQU · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ubiquitech Software Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ubiquitech Software Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ubiquitech Software Corp. develops Internet marketing and sales software solutions in the United States. The company's Internet sales technologies include Blue Crush Monetization System that creates advertising platforms and improves existing platforms to increase sales; InternationalFortune.com, a lead generation portal for currency trading companies, hedge funds, and other asset managers worldwide; and Blue Crush Connect, a social network that rewards and incentivizes customers. It also operates AffiliateCashExpress.com and NeedFunded.com. Ubiquitech Software Corp. was incorporated in 2007 and is based in Denver, Colorado.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:26 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.44+$0.02 (+4.76%)
Bio Essence Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.89% below the high.
$0.00+$0.00 (+16.67%)
Integrated Cannabis Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.83% below the high.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
$0.02-$0.01 (-20.0%)
Rafarma Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.49% below the high.
$0.00+$0.00 (+50.0%)
LiveWire Ergogenics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.57% below the high.
CA$0.01CA$0.00 (0.0%)
Pharmadrug Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Resilient Healthcare Corp’s quoted price sits in the lower half of its reported 52-week range, 92.98% below the high.
$0.00$0.00 (0.0%)
StateHouse Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.33% below the high.
